SCHEMBL9890265

SCHEMBL9890265

c1ccc2c(c1)oc1ccc(-c3cccc4c3oc3cc5c(cc34)oc3c(-n4c6ccccc6c6ccccc64)cccc35)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.51
PRKDC P78527 5/20 0.46
GGPS1 O95749 1/20 0.42
PTGES2 Q9H7Z7 1/20 0.37
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
MAPT P10636 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
AHR P35869 2/20 0.35
NPC1 O15118 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ATM Q13315 1/20 0.35
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
PIK3CD O00329 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9890262 0.97 ALOX5 (0.48) ALOX5PRKDCGGPS1PTGES2HSP90AA1
SCHEMBL22106831 0.96 ALOX5 (0.54) ALOX5PRKDCGGPS1PTGES2HSP90AA1
SCHEMBL9890277 0.92 ALOX5 (0.43) ALOX5PRKDCGGPS1PTGES2
SCHEMBL23433214 0.92 ALOX5 (0.50) ALOX5PRKDCGGPS1PTGES2HSP90AA1
SCHEMBL17248339 0.91 ALOX5 (0.54) ALOX5PRKDCGGPS1PTGES2MEN1
SCHEMBL26530238 0.91 ALOX5 (0.54) ALOX5PRKDCGGPS1PTGES2MAPT
SCHEMBL23433490 0.90 PRKDC (0.46) ALOX5PRKDCGGPS1PTGES2AHR
SCHEMBL23433492 0.90 PRKDC (0.40) ALOX5PRKDCHSP90AA1HSP90AB1MAPT
SCHEMBL5028287 0.90 ALOX5 (0.53) ALOX5PRKDCGGPS1PTGES2MEN1
SCHEMBL21343303 0.90 ALOX5 (0.42) ALOX5PRKDCGGPS1HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 ALOX5 2756/4885PRKDC 2162/4885GGPS1 1114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.